ArticleBiology open2026
Fructose impairs brown adipogenesis by promoting thyroid hormone resistance in differentiated brown adipocytes.
Article in Biology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Excessive fructose consumption is increasingly linked to obesity, diabetes, non-alcoholic fatty liver disease (NAFLD), and cardiovascular disease, yet its impact on brown adipocytes remains poorly defined. Here, we investigated how fructose alters brown adipogenesis with a focus on thyroid hormone receptor (THR) signaling. Differentiation of mouse brown preadipocytes in fructose-containing medium resulted in markedly reduced lipid droplet size and number, impaired expression of adipogenic markers (PPARγ, FABP4), and a loss of the brown adipocyte identity protein UCP-1. Whereas triiodothyronine (T3) and the THRβ-selective agonist resmetirom dose-dependently enhanced UCP-1 expression in glucose medium, neither T3 nor resmetirom restored UCP-1 in fructose medium, revealing thyroid hormone resistance. Mechanistically, fructose specifically downregulated THR but not its heterodimer partner, retinoid X receptor (RXR), via ubiquitin-mediated degradation. Overexpression of THR rescued UCP-1 in glucose medium and promoted dynamic lipid turnover but failed to restore UCP-1 or lipid remodeling in fructose medium, indicating a defect in THR transcriptional regulation. Our secretome proteomics revealed that both the sugar source and THR overexpression strongly remodel the secreted protein landscape of brown adipocytes. The data indicate that fructose both reconfigures metabolic and signaling networks and blunts oxidative resilience, while excess THR activity in fructose conditions disrupts energy metabolism and increases the risk of protein misfolding. All these could contribute to THR dysfunction and impair adipogenesis. Collectively, these findings identify fructose as a potent inhibitor of brown adipogenesis, suppressing THR-dependent UCP-1 expression by inducing thyroid hormone resistance through a defect in THR-mediated transcriptional regulation. This mechanism links dietary fructose to impaired brown adipocytes and metabolic imbalance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.